Precision Optics Corporation, Inc. (POCI)
USD 5.01
(0.2%)
USD 5.01
(0.2%)
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 | 19.1 Million USD | -9.22% |
| 2023 | 21.04 Million USD | 34.23% |
| 2022 | 15.67 Million USD | 46.87% |
| 2021 | 10.67 Million USD | 7.57% |
| 2020 | 9.92 Million USD | 45.84% |
| 2019 | 6.8 Million USD | 68.5% |
| 2018 | 4.03 Million USD | 28.01% |
| 2017 | 3.15 Million USD | -19.46% |
| 2016 | 3.91 Million USD | 0.12% |
| 2015 | 3.91 Million USD | 7.15% |
| 2014 | 3.65 Million USD | 44.9% |
| 2013 | 2.51 Million USD | 17.07% |
| 2012 | 2.15 Million USD | -4.13% |
| 2011 | 2.24 Million USD | -27.45% |
| 2010 | 3.09 Million USD | -12.3% |
| 2009 | 3.52 Million USD | 21.58% |
| 2008 | 2.9 Million USD | 17.14% |
| 2007 | 2.47 Million USD | 8.44% |
| 2006 | 2.28 Million USD | 69.26% |
| 2005 | 1.34 Million USD | -7.86% |
| 2004 | 1.46 Million USD | -38.94% |
| 2003 | 2.39 Million USD | 35.22% |
| 2002 | 1.77 Million USD | -58.23% |
| 2001 | 4.24 Million USD | 41.14% |
| 2000 | 3 Million USD | 0.32% |
| 1999 | 3 Million USD | -26.83% |
| 1998 | 4.1 Million USD | -44.59% |
| 1997 | 7.4 Million USD | -8.64% |
| 1996 | 8.1 Million USD | 6.58% |
| 1995 | 7.6 Million USD | 7.04% |
| 1994 | 7.1 Million USD | 47.92% |
| 1993 | 4.8 Million USD | -17.24% |
| 1992 | 5.8 Million USD | 31.82% |
| 1991 | 4.4 Million USD | 0.0% |
| Year | Revenue | Revenue Growth |
|---|---|---|
| 2024 Q2 | 4.82 Million USD | 11.64% |
| 2024 Q4 | 4.71 Million USD | -10.04% |
| 2024 Q1 | 4.32 Million USD | -13.99% |
| 2024 Q3 | 5.24 Million USD | 8.67% |
| 2023 Q4 | 5.02 Million USD | -0.47% |
| 2023 Q3 | 5.04 Million USD | -14.25% |
| 2023 Q2 | 5.88 Million USD | 15.76% |
| 2023 Q1 | 5.08 Million USD | 6.09% |
| 2023 FY | 21.04 Million USD | 34.23% |
| 2022 Q4 | 4.79 Million USD | 3.06% |
| 2022 FY | 15.67 Million USD | 46.87% |
| 2022 Q1 | 2.33 Million USD | -12.6% |
| 2022 Q2 | 3.89 Million USD | 66.8% |
| 2022 Q3 | 4.65 Million USD | 19.36% |
| 2021 Q2 | 2.78 Million USD | 1.0% |
| 2021 Q4 | 2.67 Million USD | 8.74% |
| 2021 FY | 10.67 Million USD | 7.57% |
| 2021 Q1 | 2.75 Million USD | 23.28% |
| 2021 Q3 | 2.45 Million USD | -11.75% |
| 2020 Q3 | 2.37 Million USD | -15.1% |
| 2020 Q1 | 2.51 Million USD | 5.65% |
| 2020 FY | 9.92 Million USD | 45.84% |
| 2020 Q4 | 2.23 Million USD | -5.79% |
| 2020 Q2 | 2.79 Million USD | 11.2% |
| 2019 Q1 | 1.55 Million USD | 6.74% |
| 2019 Q2 | 1.47 Million USD | -5.23% |
| 2019 Q4 | 2.38 Million USD | 71.69% |
| 2019 FY | 6.8 Million USD | 68.5% |
| 2019 Q3 | 1.38 Million USD | -6.18% |
| 2018 Q4 | 1.46 Million USD | 98.6% |
| 2018 FY | 4.03 Million USD | 28.01% |
| 2018 Q1 | 1.02 Million USD | 42.84% |
| 2018 Q2 | 812.77 Thousand USD | -20.99% |
| 2018 Q3 | 735.59 Thousand USD | -9.5% |
| 2017 Q3 | 983.18 Thousand USD | 63.43% |
| 2017 FY | 3.15 Million USD | -19.46% |
| 2017 Q1 | 849.54 Thousand USD | -11.75% |
| 2017 Q2 | 601.59 Thousand USD | -29.19% |
| 2017 Q4 | 720.22 Thousand USD | -26.75% |
| 2016 FY | 3.91 Million USD | 0.12% |
| 2016 Q3 | 1.14 Million USD | 19.49% |
| 2016 Q2 | 954.77 Thousand USD | 11.22% |
| 2016 Q1 | 858.42 Thousand USD | -10.85% |
| 2016 Q4 | 962.67 Thousand USD | -15.62% |
| 2015 Q3 | 1.14 Million USD | 16.93% |
| 2015 FY | 3.91 Million USD | 7.15% |
| 2015 Q2 | 976.54 Thousand USD | 17.56% |
| 2015 Q1 | 830.71 Thousand USD | -7.96% |
| 2015 Q4 | 962.9 Thousand USD | -15.67% |
| 2014 Q1 | 907.42 Thousand USD | 13.1% |
| 2014 Q3 | 833.45 Thousand USD | -17.29% |
| 2014 FY | 3.65 Million USD | 44.9% |
| 2014 Q2 | 1 Million USD | 11.05% |
| 2014 Q4 | 902.58 Thousand USD | 8.3% |
| 2013 Q1 | 563.39 Thousand USD | -26.98% |
| 2013 Q4 | 802.33 Thousand USD | 22.43% |
| 2013 Q2 | 498.66 Thousand USD | -11.49% |
| 2013 Q3 | 655.34 Thousand USD | 31.42% |
| 2013 FY | 2.51 Million USD | 17.07% |
| 2012 FY | 2.15 Million USD | -4.13% |
| 2012 Q3 | 382.26 Thousand USD | -22.58% |
| 2012 Q2 | 493.77 Thousand USD | -2.17% |
| 2012 Q1 | 504.74 Thousand USD | -19.89% |
| 2012 Q4 | 771.6 Thousand USD | 101.85% |
| 2011 FY | 2.24 Million USD | -27.45% |
| 2011 Q1 | 683.9 Thousand USD | -26.78% |
| 2011 Q2 | 435.77 Thousand USD | -36.28% |
| 2011 Q3 | 495.42 Thousand USD | 13.69% |
| 2011 Q4 | 630.04 Thousand USD | 27.17% |
| 2010 Q4 | 934.07 Thousand USD | 9.77% |
| 2010 Q2 | 686.03 Thousand USD | 10.05% |
| 2010 Q3 | 850.93 Thousand USD | 24.04% |
| 2010 Q1 | 623.38 Thousand USD | -38.36% |
| 2010 FY | 3.09 Million USD | -12.3% |
| 2009 Q1 | 659.73 Thousand USD | 14.18% |
| 2009 FY | 3.52 Million USD | 21.58% |
| 2009 Q2 | 960.71 Thousand USD | 45.62% |
| 2009 Q3 | 896.66 Thousand USD | -6.67% |
| 2009 Q4 | 1.01 Million USD | 12.8% |
| 2008 FY | 2.9 Million USD | 17.14% |
| 2008 Q2 | 579.63 Thousand USD | -47.39% |
| 2008 Q1 | 1.1 Million USD | -0.91% |
| 2008 Q4 | 577.81 Thousand USD | -10.14% |
| 2008 Q3 | 643.04 Thousand USD | 10.94% |
| 2007 Q3 | 4.67 Million USD | 892.33% |
| 2007 FY | 2.47 Million USD | 8.44% |
| 2007 Q4 | 1.11 Million USD | -76.2% |
| 2007 Q2 | 470.81 Thousand USD | -0.79% |
| 2007 Q1 | 474.54 Thousand USD | -24.9% |
| 2006 Q2 | 529.19 Thousand USD | 26.12% |
| 2006 Q1 | 419.58 Thousand USD | 15.84% |
| 2006 FY | 2.28 Million USD | 69.26% |
| 2006 Q4 | 631.9 Thousand USD | -10.24% |
| 2006 Q3 | 704.01 Thousand USD | 33.03% |
| 2005 Q2 | 397.52 Thousand USD | 50.68% |
| 2005 Q4 | 362.21 Thousand USD | 11.02% |
| 2005 Q3 | 326.27 Thousand USD | -17.92% |
| 2005 Q1 | 263.81 Thousand USD | -7.62% |
| 2005 FY | 1.34 Million USD | -7.86% |
| 2004 Q1 | 638.8 Thousand USD | 75.52% |
| 2004 Q4 | 285.57 Thousand USD | -8.96% |
| 2004 Q3 | 313.69 Thousand USD | 38.26% |
| 2004 Q2 | 226.88 Thousand USD | -64.48% |
| 2004 FY | 1.46 Million USD | -38.94% |
| 2003 Q1 | 542.44 Thousand USD | -9.74% |
| 2003 Q4 | 363.94 Thousand USD | -59.7% |
| 2003 Q3 | 903.06 Thousand USD | 53.12% |
| 2003 Q2 | 589.75 Thousand USD | 8.72% |
| 2003 FY | 2.39 Million USD | 35.22% |
| 2002 FY | 1.77 Million USD | -58.23% |
| 2002 Q2 | 323.31 Thousand USD | -34.16% |
| 2002 Q1 | 491.09 Thousand USD | -66.06% |
| 2002 Q3 | 358.89 Thousand USD | 11.01% |
| 2002 Q4 | 600.97 Thousand USD | 67.45% |
| 2001 Q1 | 888.29 Thousand USD | -3.54% |
| 2001 FY | 4.24 Million USD | 41.14% |
| 2001 Q3 | 1.13 Million USD | 45.66% |
| 2001 Q4 | 1.44 Million USD | 27.6% |
| 2001 Q2 | 778.53 Thousand USD | -12.36% |
| 2000 FY | 3 Million USD | 0.32% |
| 2000 Q4 | 920.85 Thousand USD | 17.38% |
| 2000 Q3 | 784.5 Thousand USD | 30.75% |
| 2000 Q2 | 600 Thousand USD | -14.29% |
| 2000 Q1 | 700 Thousand USD | 0.0% |
| 1999 FY | 3 Million USD | -26.83% |
| 1999 Q1 | 700 Thousand USD | -22.22% |
| 1999 Q2 | 900 Thousand USD | 28.57% |
| 1999 Q3 | 800 Thousand USD | -11.11% |
| 1999 Q4 | 700 Thousand USD | -12.5% |
| 1998 FY | 4.1 Million USD | -44.59% |
| 1998 Q4 | 900 Thousand USD | -18.18% |
| 1998 Q1 | 1 Million USD | -23.08% |
| 1998 Q2 | 1.1 Million USD | 10.0% |
| 1998 Q3 | 1.1 Million USD | 0.0% |
| 1997 Q3 | 1.3 Million USD | -40.91% |
| 1997 Q1 | 2.6 Million USD | 8.33% |
| 1997 Q4 | 1.3 Million USD | 0.0% |
| 1997 FY | 7.4 Million USD | -8.64% |
| 1997 Q2 | 2.2 Million USD | -15.38% |
| 1996 FY | 8.1 Million USD | 6.58% |
| 1996 Q2 | 1.8 Million USD | -10.0% |
| 1996 Q1 | 2 Million USD | -16.67% |
| 1996 Q4 | 2.4 Million USD | 26.32% |
| 1996 Q3 | 1.9 Million USD | 5.56% |
| 1995 Q4 | 2.4 Million USD | 26.32% |
| 1995 Q2 | 1.7 Million USD | 13.33% |
| 1995 Q1 | 1.5 Million USD | -28.57% |
| 1995 FY | 7.6 Million USD | 7.04% |
| 1995 Q3 | 1.9 Million USD | 11.76% |
| 1994 Q3 | 1.9 Million USD | 18.75% |
| 1994 Q1 | 1.5 Million USD | 15.38% |
| 1994 Q2 | 1.6 Million USD | 6.67% |
| 1994 FY | 7.1 Million USD | 47.92% |
| 1994 Q4 | 2.1 Million USD | 10.53% |
| 1993 Q1 | 900 Thousand USD | -30.77% |
| 1993 Q4 | 1.3 Million USD | -13.33% |
| 1993 Q3 | 1.5 Million USD | 36.36% |
| 1993 FY | 4.8 Million USD | -17.24% |
| 1993 Q2 | 1.1 Million USD | 22.22% |
| 1992 FY | 5.8 Million USD | 31.82% |
| 1992 Q2 | 1.5 Million USD | -6.25% |
| 1992 Q1 | 1.6 Million USD | 45.45% |
| 1992 Q4 | 1.3 Million USD | -7.14% |
| 1992 Q3 | 1.4 Million USD | -6.67% |
| 1991 Q1 | 1.1 Million USD | 0.0% |
| 1991 Q3 | 1.1 Million USD | 0.0% |
| 1991 Q4 | 1.1 Million USD | 0.0% |
| 1991 FY | 4.4 Million USD | 0.0% |
| 1991 Q2 | 1.1 Million USD | 0.0% |
| Name | Revenue | Revenue Difference |
|---|---|---|
| Akoya Biosciences, Inc. | 96.63 Million USD | 80.23% |
| AngioDynamics, Inc. | 303.91 Million USD | 93.714% |
| AtriCure, Inc. | 399.24 Million USD | 95.215% |
| Avinger, Inc. | 7.65 Million USD | -149.665% |
| Azenta, Inc. | 665.07 Million USD | 97.127% |
| BioLife Solutions, Inc. | 143.27 Million USD | 86.666% |
| The Cooper Companies, Inc. | 3.59 Billion USD | 99.468% |
| Daxor Corporation | 1.28 Million USD | -1391.927% |
| Ekso Bionics Holdings, Inc. | 18.27 Million USD | -4.515% |
| Femasys Inc. | 1.07 Million USD | -1682.172% |
| GlucoTrack, Inc. | - USD | -Infinity% |
| Harvard Bioscience, Inc. | 112.25 Million USD | 82.981% |
| Hologic, Inc. | 4.03 Billion USD | 99.526% |
| ICU Medical, Inc. | 2.25 Billion USD | 99.154% |
| Intuitive Surgical, Inc. | 7.12 Billion USD | 99.732% |
| KORU Medical Systems, Inc. | 28.51 Million USD | 33.009% |
| LeMaitre Vascular, Inc. | 193.48 Million USD | 90.126% |
| Innovative Eyewear, Inc. | 1.15 Million USD | -1557.674% |
| Innovative Eyewear, Inc. | 1.15 Million USD | -1557.674% |
| Masimo Corporation | 2.04 Billion USD | 99.067% |
| Microbot Medical Inc. | - USD | -Infinity% |
| Meihua International Medical Technologies Co., Ltd. | 97.09 Million USD | 80.325% |
| Merit Medical Systems, Inc. | 1.25 Billion USD | 98.481% |
| Nephros, Inc. | 14.23 Million USD | -34.179% |
| NovoCure Limited | 509.33 Million USD | 96.249% |
| NEXGEL, Inc. | 4.08 Million USD | -367.213% |
| NEXGEL, Inc. | 4.08 Million USD | -367.213% |
| Singular Genomics Systems, Inc. | 2.91 Million USD | -556.281% |
| OraSure Technologies, Inc. | 405.47 Million USD | 95.288% |
| Pro-Dex, Inc. | 53.84 Million USD | 64.519% |
| Pulse Biosciences, Inc. | - USD | -Infinity% |
| Predictive Oncology Inc. | 1.78 Million USD | -973.222% |
| QuidelOrtho Corporation | 2.99 Billion USD | 99.363% |
| Repligen Corporation | 638.76 Million USD | 97.009% |
| Sanara MedTech Inc. | 64.98 Million USD | 70.604% |
| STAAR Surgical Company | 322.41 Million USD | 94.075% |
| Sharps Technology, Inc. | - USD | -Infinity% |
| Utah Medical Products, Inc. | 50.22 Million USD | 61.962% |
| DENTSPLY SIRONA Inc. | 3.96 Billion USD | 99.518% |
| Jin Medical International Ltd. | 19.82 Million USD | 3.618% |